Want to see AMRX full AI Analyst Report?
Amneal Pharmaceuticals (AMRX) Q2 2024 Earnings Report
AMRX Q2 2024 EPS Results
- Actual EPS
- $0.16
- Consensus EPS
- $0.15
- Beat/Miss
- Beat by +$0.01
- One Year Ago EPS
- $0.19
AMRX Q2 2024 Revenue Results
- Actual Revenue
- $701.78M
- Expected Revenue
- $657.52M
- Beat/Miss
- Beat by +$44.26M
- YoY Revenue Growth
- +17.15%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/09/2024
- Time
- Before Open
- Conference Call
- Friday, August 9, 2024
AMRX Upcoming Earnings
Amneal Pharmaceuticals's next earnings date is estimated for November 3, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
AMRX Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
AMRX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 03, 2026 | 2026 (Q3) | 0.24- | 0.17 | ― | ― |
| Jul 30, 2026 | 2026 (Q2) | 0.220.30 | 0.25 | 20.00% (+0.05) | |
| May 07, 2026 | 2026 (Q1) | 0.170.27 | 0.21 | 28.57% (+0.06) | |
| Feb 27, 2026 | 2025 (Q4) | 0.180.21 | 0.12 | 75.00% (+0.09) | |
| Oct 30, 2025 | 2025 (Q3) | 0.140.17 | 0.16 | 6.25% (+0.01) | |
| Aug 05, 2025 | 2025 (Q2) | 0.170.25 | 0.16 | 56.25% (+0.09) | |
| May 02, 2025 | 2025 (Q1) | 0.150.21 | 0.14 | 50.00% (+0.07) | |
| Feb 28, 2025 | 2024 (Q4) | 0.150.12 | 0.14 | -14.29% (-0.02) | |
| Nov 08, 2024 | 2024 (Q3) | 0.130.16 | 0.19 | -15.79% (-0.03) | |
| Aug 09, 2024 | 2024 (Q2) | 0.150.16 | 0.19 | -15.79% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
